Select Page

Treadwell-Therapeutics-Announces-FDA-Clearance-IND-Application

Jun 2, 2020

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 1/2 Study of HPK1 Inhibitor, CFI-402411

©2020 TIO Bioventures
Terms of Use / Legal Disclaimer
Design by D&CO
New York Office
41 Madison Avenue, 25th Floor
New York, New York, USA, 10010